和铂医药-B(02142)10月17日斥资513.49万港元回购40万股
HBM HOLDINGSHBM HOLDINGS(HK:02142) 智通财经网·2025-10-17 10:59

Core Viewpoint - The company, HAPO Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will repurchase 400,000 shares [1] - The total expenditure for the buyback is HKD 5.1349 million [1] - The buyback is scheduled for October 17, 2025 [1]